Obesity related conditions including atherosclerosis and type 2 diabetes mellitus (T2DM) have a profound effect on cardiovascular health and morbidity. Recent reports by Akbari et. al. indicate that truncated loss of function variants of the orphan G-protein coupled receptor, GPR75, are associated with 5.3 kg lower bodyweight and 54% lower odds of obesity in heterozygous individuals (Science, 2021) . Based on these findings, we hypothesized that whole body deletion of Gpr75 protects against diet-induced obesity (DIO) and the resulting insulin resistance. Wild-type and Gpr75 null mice were subjected to 14 weeks of regular chow or high-fat diet (HFD) feeding. Body weight, intraperitoneal glucose and insulin tolerance tests, and pro-inflammatory cytokine gene expressions were measured initially and at week 14. There were no significant differences in body weight, glucose homeostasis, and tumor necrosis factor alpha (TNF-α) expression between wild-type (WT) and Gpr75-/- (KO) mice at baseline. However, WT mice obtained a diabetogenic phenotype after HFD-feeding while the KO counterparts were protected as indicated by reduced body weight, (45.32 ± 1.387 grams vs. 28.29 ± 1.47 grams) and increased sensitivity to insulin (blood glucose 30 min after insulin injection as percent change, -28.5 ± 4.41% vs. -50.68 ± 4.15%, p<0.0001) . This correlated with a 1.98-fold decrease in brown adipose tissue (BAT) and 2.31-fold decrease in subcutaneous adipose tissue (SAT) TNF-α mRNA expression in KO compared to WT mice. Furthermore, there was a 3.19-fold reduction in circulating chemokine ligand 5 (CCL5) in KO compared to WT mice. This data may provide a potential novel target for the control of obesity-driven disorders such as inflammation and insulin resistance.


S. Hossain: None. E. Dirice: None.



Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.